Esther Wai Yin Chan Selected Research

BNT162 Vaccine

12/2022	Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study.
12/2022	Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study.
11/2022	Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
6/2022	mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
4/2022	Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.
3/2022	Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study.
1/2022	Post-Covid-19-vaccination adverse events and healthcare utilization among individuals with or without previous SARS-CoV-2 infection.
1/2022	Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
1/2022	Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
1/2022	COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Esther Wai Yin Chan Research Topics

Disease

10	COVID-19 11/2022 - 01/2022
3	Bell Palsy (Bell's Palsy) 06/2022 - 01/2022
2	Myocarditis (Carditis) 12/2022 - 01/2022
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2022
2	Infections 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022
1	Herpes Zoster 04/2022
1	Leukopenia 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Rheumatoid Arthritis 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Hypothyroidism 01/2022
1	Neutropenia 01/2022
1	Pericarditis 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thromboembolism 01/2022
1	Kidney Diseases (Kidney Disease) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020

Drug/Important Bio-Agent (IBA)

13	BNT162 VaccineIBA 12/2022 - 01/2022
10	sinovac COVID-19 vaccineIBA 11/2022 - 01/2022
9	VaccinesIBA 12/2022 - 01/2022
7	Messenger RNA (mRNA)IBA 12/2022 - 01/2022
7	COVID-19 VaccinesIBA 12/2022 - 01/2022
4	insulin receptor-related receptor (IRR)IBA 12/2022 - 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	TroponinIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	LDL CholesterolIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	CholesterolIBA 01/2021
1	AlbuminsIBA 01/2021
1	CreatinineIBA 01/2021
1	LipidsIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2020